Lipid Chaperones and Metabolic Inflammation

by Masato Furuhashi, Shutaro Ishimura, Hideki Ota, Tetsuji Miura
Published 2011-01-01

Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.

by Masato Furuhashi, Shutaro Ishimura, Hideki Ota, Manabu Hayashi, Takahiro Nishitani, Marenao Tanaka, Hideaki Yoshida, Kazuaki Shimamoto, Gökhan S Hotamisligil, Tetsuji Miura
Published 2011-01-01

Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.

by Yusuke Okazaki, Masato Furuhashi, Marenao Tanaka, Tomohiro Mita, Takahiro Fuseya, Shutaro Ishimura, Yuki Watanabe, Kyoko Hoshina, Hiroshi Akasaka, Hirofumi Ohnishi, Hideaki Yoshida, Shigeyuki Saitoh, Kazuaki Shimamoto, Tetsuji Miura
Published 2014-01-01

Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population.

by Shutaro Ishimura, Masato Furuhashi, Yuki Watanabe, Kyoko Hoshina, Takahiro Fuseya, Tomohiro Mita, Yusuke Okazaki, Masayuki Koyama, Marenao Tanaka, Hiroshi Akasaka, Hirofumi Ohnishi, Hideaki Yoshida, Shigeyuki Saitoh, Tetsuji Miura
Published 2013-01-01

Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus

by Masato Furuhashi, Shinya Hiramitsu, Tomohiro Mita, Takahiro Fuseya, Shutaro Ishimura, Akina Omori, Megumi Matsumoto, Yuki Watanabe, Kyoko Hoshina, Marenao Tanaka, Norihito Moniwa, Hideaki Yoshida, Junnichi Ishii, Tetsuji Miura
Published 2015-12-01